Top Markets
Coin of the day
Pharmanutra S.p.A. Pharmanutra S.p.A.

Pharmanutra S.p.A.

PHN
Hisse Senetlerindeki Sıralama #9895
Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise,... Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.
Hisse Fiyatı
$97.03
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$929.06M
Değişim (1 gün)
-0.12%
Değişim (1 yıl)
70.33%
Ülke
IT
Ticaret Pharmanutra S.p.A. (PHN)

Kategori

Pharmanutra S.p.A. (PHN) için P/B oranı
2026 itibarıyla P/B oranı TTM: 0
Pharmanutra S.p.A. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/B oranı 0 idi.
Pharmanutra S.p.A. için P/B oranı geçmişi 2026 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/B oranı